期刊文献+

甲状腺功能亢进对稳定性心绞痛患者发生心房颤动的影响

Effect of hyperthyroidism on the incidence of atrial fibrillation in patients with stable angina
下载PDF
导出
摘要 目的甲状腺功能亢进对稳定性心绞痛患者发生心房颤动的影响。方法纳入将2012年7月至2014年6月我院收治的稳定性心绞痛患者567例为研究对象,根据患者血浆中TSH水平分成3组,即TSH〈0.55 m IU/L组、0.55~4.78m IU/L组、〉4.78 m IU/L组。比较3组患者的实验室检查结果,并观察不同组别患者的房颤发生率。结果 567例稳定性心绞痛患者中,44例诊断为阵发性或持续性房颤,发生率为7.8%。TSH在0.55~4.78 m IU/L时房颤发生率最低,为6.4%(30/503);TSH〉4.78 m IU/L时发生率最高,为19.5%(8/41),而TSH在〈0.55 m IU/L时房颤发生率为17.4%(4/23),组间比较差异有统计学意义(P=0.001)。甲状腺功能亢进与稳定性心绞痛患者发生房颤存在相关性。结论甲状腺功能亢进与稳定性心绞痛患者房颤的发生相关。 Objective To explore the effect of hyperthyroidism on the incidence of atrial fibrillation in patients with stable angi -na.Methods 567 patients with stable angina from 2012 Jul to 2014 Jun were included in this analysis .All patients with thyroid function test results were divided into 3 groups according to TSH levels:〈0.55 mIU/L、0.55~4.78 mIU/L and 〉4.78 mIU/L.Gen-eral clinical data and related biochemical parameters were analyzed .Results A total of 44 patients were diagnosed with AF (7.8%). When the concentration of TSH was 0.55~4.78 mIU/L, the atrial fibrillation incidence rate was 6.4% (30/503), which was the lowest;When the concentration of TSH was above 4.78 mIU/L, the atrial fibrillation incidence rate was 19.5%(8/41), which was the highest;When the concentration of TSH was below 0.55 mIU/L, the incidence of atrial fibrillation was17 .4%(4/23), the differ-ence between groups was statistically significant (P=0.001).There was correlation between Hyperthyroidism and atrial fibrillation in patients with stable angina .Conclusion Our results show that the incidence of AF increases in proportion to TSH level in patients with stable angina .
出处 《牡丹江医学院学报》 2015年第3期29-31,共3页 Journal of Mudanjiang Medical University
关键词 稳定性心绞痛 甲状腺功能亢进 心房颤动 危险因素 Stable angina Hyperthyroidism Atrial fibrillation Risk factors
  • 相关文献

参考文献15

  • 1Karras S, Tzotzas T, Kaltsas T, et aI. Pharmaco/ogiea] treatment of hyperthyroidism during lactation: review of the literature and novel data [ J]. Pediatr EndoerinoI Rev,2010,8 (1) :25 -33.
  • 2Ghandour A, Reust C. Hyperthyroidism: a stepwise approach to management [ J ]. J Fam Pratt,2011,60 ( 7 ) : 388 - 395.
  • 3Mansourian AR. A review of literature on the adverse effects of hy- perthyroidism on the heart functional behavior J]. Pak .1 BioI Sei,2012,15 (4) : 164 - 176.
  • 4Rakhmatullov FK, Klimova SV, Rudakova LE, et al. The influ-ence of subclinical thyroid dysfunction on cardiac hemodynamie and eleclmphysiological parameters in patients with coronary heart disease and paroxysmal atrial fibrillation [ J ]. Klin Med ( Mosk ) , 2012,90:31 - 34.
  • 5无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2053
  • 6Lip GY, Halperin JL, Tse HF. The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation:an evolution or revolution.'? [ J]. Chest,2011,139 (8) :738 - 741.
  • 7何森,王斯,陈晓平.心房颤动发病机制的研究进展[J].华西医学,2012,27(5):794-797. 被引量:20
  • 8王笑,刘志华.甲状腺功能亢进并发心血管疾病的研究进展[J].心血管病学进展,2011,32(3):445-447. 被引量:14
  • 9Stavrakis S, Yu X, Patterson E, et al. Activating autoantibodies to the beta - 1 adrenergic and M2 muscarinic receptors facilitate at- rial fibrillation in patients with Graves' hyperthyroidism [ J]. J Am Coll Cardiol, 2009, 54(14) : 1309 -1316.
  • 10Biondi B, Kahaly GJ. Cardiovascular involvement in patients with different causes of hyperthyroidism [ J]. Nat Rev Endocri- nol, 2010, 6(8) :431 -443.

二级参考文献95

  • 1毛文文.甲状腺功能亢进性心脏病的预防和治疗[J].医学综述,2004,10(12):729-731. 被引量:7
  • 2刘灵芝,刘恒亮,武恩平.甲状腺功能亢进性心脏病32例临床分析[J].河南职工医学院学报,2006,18(2):111-113. 被引量:2
  • 3吴卫,柯丹,许春萱,邓玉莲,陈林,张建成,林亚洲,胡锡衷.Ⅰ型胶原和白细胞介素-1β在心房颤动患者心房中的表达[J].中华内科杂志,2006,45(10):807-810. 被引量:10
  • 4唐元升,朱兴雷.心房颤动治疗的新进展[J].中国实用内科杂志,1997,17(2):118-119. 被引量:8
  • 5Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 6Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 7Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 8Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 9O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 10Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.

共引文献2085

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部